Unmatched resources will enable researchers to identify distinctive disease mechanisms in small patient subgroups, supporting the development of custom therapeutic approaches.
Read More
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read More
The research panels can be performed using Qiagen’s GeneReader NGS system and other platforms, providing deep analysis of disease-related genomic mutations.
Read More
The company anticipates a $10 million annual European market, with $1 million in annual addressable sales potential from its local partner it Italy.
Read More